FDA’s Office Of Regulatory Affairs Scrutinizes Recalls Process

Improving the efficiency of the recall process is one of ORA’s priorities for fiscal 2012. And CDRH says its own recall improvements efforts are starting to bear fruit.

More from Regulation

More from Policy & Regulation